Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    NCT01262365
Show Display Options
Rank Status Study
1 Completed Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Epratuzumab;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.